Rallis India is currently trading at Rs 208.45, up by 2.35 points or 1.14% from its previous closing of Rs. 206.10 on the BSE.
The scrip opened at Rs. 208.65 and has touched a high and low of Rs. 209.85 and Rs. 201.10 respectively. So far 5183 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 273.80 on 15-Jul-2015 and a 52 week low of Rs. 142.00 on 21-Jan-2016.
Last one week high and low of the scrip stood at Rs 216.45 and Rs 201.10 respectively. The current market cap of the company is Rs 4064.40 crore.
The promoters holding in the company stood at 50.09% while Institutions and Non-Institutions held 20.19% and 29.72% respectively.
Rallis India’s wholly-owned subsidiary Metahelix Life Sciences (Metahelix), has entered into a Joint Venture (JV) with Indonesian local partner for the establishment of a seed production and distribution company viz. PT Metahelix Lifesciences Indonesia. Metahelix will have 49% stake in the PT Metahelix Lifesciences Indonesia.
The current paid up capital of the JV entity is $1,25,000 which will be increased to $2,50,000 by March 2017. Metahelix and the JV partner will invest in the paid up capital to the extent of their share in the JV, viz, 49% and 51%, respectively.
The JV company will engage in the activity of seed production, processing and/or packing, importing or purchasing parent seeds and distributing and trading of JV seeds under any model of distribution within the area of the Republic of Indonesia. The objective of the formation of this JV is to expand the Metahelix's seed business in relevant crops in South-East Asia.
Rallis India is a major agri-solution provider company in India. The company has been associated with the farming community for the past over 160 years and continuously strives to improve farm productivity through innovative product & service offerings.
| Company Name | CMP |
|---|---|
| UPL | 665.00 |
| PI Industries | 3144.45 |
| Bayer CropScience | 4900.45 |
| Sharda Cropchem | 1109.70 |
| Sumitomo Chemical | 441.95 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: